TABLE 1

ASP-Targeted Antimicrobial Agents Requiring ASP Review in the Prospective Audit Period and Restricted Antimicrobial Agents Requiring a Pediatric Infectious Diseases Consult

AntibacterialAntiviralAntifungal
ASP reviews at 48–72 h
AmikacinGanciclovirAmbisome
CefepimeValganiciclovirAmphotericin B Lipid Complex
CeftazidineCaspofungin
CiprofloxacinMicafungin
Clindamycin
Ertapenem
Levofloxacin
Meropenem
Piperacillin-tazobactam
Rifampin
Tobramycin
Vancomycin
Restricted and pediatric ID consulted if ordered
DaptomycinFlucytosine
Polymixin B SulfateVoriconazole
Linezolid
Tigecycline